These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27119233)
1. Expression and prognostic significance of CCL11/CCR3 in glioblastoma. Tian M; Chen L; Ma L; Wang D; Shao B; Wu J; Wu H; Jin Y Oncotarget; 2016 May; 7(22):32617-27. PubMed ID: 27119233 [TBL] [Abstract][Full Text] [Related]
2. CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Miyagaki T; Sugaya M; Murakami T; Asano Y; Tada Y; Kadono T; Okochi H; Tamaki K; Sato S Cancer Res; 2011 Mar; 71(6):2056-65. PubMed ID: 21406396 [TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR7 is an independent prognostic biomarker in glioblastoma. Deng L; Zheng W; Dong X; Liu J; Zhu C; Lu D; Zhang J; Song L; Wang Y; Deng D Cancer Biomark; 2017 Jul; 20(1):1-6. PubMed ID: 28759950 [TBL] [Abstract][Full Text] [Related]
4. CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs. Park JY; Kang YW; Choi BY; Yang YC; Cho BP; Cho WG J Recept Signal Transduct Res; 2017 Aug; 37(4):416-421. PubMed ID: 28279120 [TBL] [Abstract][Full Text] [Related]
5. Rapid and transient upregulation of CCL11 (eotaxin-1) in mouse ovary during terminal stages of follicular development. Kuwabara Y; Katayama A; Igarashi T; Tomiyama R; Piao H; Kaneko R; Abe T; Mine K; Akira S; Orimo H; Takeshita T Am J Reprod Immunol; 2012 May; 67(5):358-68. PubMed ID: 22221885 [TBL] [Abstract][Full Text] [Related]
6. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
7. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression. Sun J; Zhao B; Du K; Liu P Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666 [TBL] [Abstract][Full Text] [Related]
8. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway. Cheng P; Ma Y; Gao Z; Duan L Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692 [TBL] [Abstract][Full Text] [Related]
9. Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression. Zhu F; Liu P; Li J; Zhang Y Oncol Rep; 2014 May; 31(5):2049-54. PubMed ID: 24604010 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288 [TBL] [Abstract][Full Text] [Related]
15. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target? Vasaikar S; Tsipras G; Landázuri N; Costa H; Wilhelmi V; Scicluna P; Cui HL; Mohammad AA; Davoudi B; Shang M; Ananthaseshan S; Strååt K; Stragliotto G; Rahbar A; Wong KT; Tegner J; Yaiw KC; Söderberg-Naucler C BMC Cancer; 2018 Feb; 18(1):154. PubMed ID: 29409474 [TBL] [Abstract][Full Text] [Related]
17. Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11-CCR3 pathway. Bekaert S; Rocks N; Vanwinge C; Noel A; Cataldo D Respir Res; 2021 Feb; 22(1):61. PubMed ID: 33608009 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9. Ji T; Zhang X; Li W Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046 [TBL] [Abstract][Full Text] [Related]
19. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma. Wang Y; Su Y; Ji Z; Lv Z Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936 [TBL] [Abstract][Full Text] [Related]
20. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]